Why are these shelves empty? Ohio Governor Mike DeWine passed an emergency measure to prohibit sales of “intoxicating hemp products.”
If you are an Ohio resident, contact your representative to support access to legal hemp products in Ohio and ask them to reconsider the emergency ban, or join thousands of Ohioans and sign this petition to reverse the executive order.
New Laws & Emerging Regulations on CBD, THC, and Hemp in the U.S. (2025-2026 Update)

New Laws & Emerging Regulations on CBD, THC, and Hemp in the U.S. (2025-2026 Update)

Law Changes to HEMP, THC and CBD Products Are Coming

The legal status of CBD, THC, and hemp continues to be in flux throughout 2025. As science evolves, public awareness increases, and economic stakes grow, legislators and regulators at both state and federal levels are pushing through changes. This isn’t just about whether hemp is legal (it generally is, if it meets certain THC thresholds), but how products are made, labeled, marketed, sold—and even whether certain cannabinoids remain legal at all.

In this article, we’ll cover the who, what, where, when, and why of new laws affecting CBD, THC, and hemp: current proposals, recent bills, state-law shifts, and emerging legal risks & protections.

Key Terms & Context

To avoid confusion:

  • Hemp: Typically defined under the U.S. Agriculture Improvement Act of 2018 (the 2018 Farm Bill) as Cannabis sativa L. and those parts of the plant with no more than 0.3% Δ⁹-THC on a dry weight basis. Hemp is not a controlled substance under federal law if it meets that threshold. (ams.usda.gov)
  • THC (Tetrahydrocannabinol): The psychoactive cannabinoid that gives the “high.” Δ⁹-THC is the primary concern. There are also other isomers (delta-8, delta-10, etc.) which are in legal gray areas or being restricted.
  • CBD (Cannabidiol): Non-intoxicating cannabinoid, legal under many state laws if derived from hemp (less than 0.3 % THC), though regulation is rapidly catching up.

What’s Changing: Federal Level

Proposed Redefinition of Hemp

  • One of the most significant proposals in Congress would change the legal limit from “≤ 0.3% Δ⁹-THC” in hemp to a requirement of “no quantifiable amount” (i.e. essentially zero detectable THC). (marijuanamoment.net)
  • This could sweep up many full-spectrum CBD products that currently include trace THC—products that are legal under many state regimes but would become illegal under stricter federal definitions. (marijuanamoment.net)

Banning “Intoxicating Hemp Products”

  • There is a push in certain appropriations and regulatory bills to ban consumable hemp products with any measurable intoxicating cannabinoids (this includes delta-8, delta-9, synthetic derivatives). (foleyhoag.com)
  • The reasoning behind this is concern over unregulated products that mimic conventional THC products, often with appealing packaging and unclear labeling, which some lawmakers say are marketed to younger consumers. (cannabisbusinesstimes.com)

Regulatory Oversight

  • The U.S. Department of Agriculture (USDA) continues to oversee hemp under federal law. Under current law, hemp with more than 0.3% Δ⁹-THC is treated as a controlled substance. (ams.usda.gov)
  • There are growing calls for stricter labeling, batch testing, and clearer enforcement mechanisms.

What’s Changing: State Level (Selected States)

Because laws vary a lot state by state, here are a few recent or upcoming changes that are especially noteworthy.

Texas

  • Senate Bill 3 (2025) proposed to ban almost all hemp-derived THC products, except for CBD and CBG. It passed the legislature but was vetoed by Governor Greg Abbott in June 2025. (en.wikipedia.org)
  • However, Abbott indicated a preference for regulation rather than prohibition, and there may be special sessions to work on stricter regulatory frameworks—such as age limits, packaging restrictions, warning labels, etc. (austin.eater.com)
  • Also, Senate Bill 2024, which bans the sale, marketing, and advertising of vape pens containing cannabinoids (THC, CBD, delta-8 THC, THCA) (especially targeting minors), went into effect September 1, 2025. (statesman.com)

Tennessee

  • Tennessee passed laws in its latest legislative session that go into effect January 1, 2026, which impose tougher requirements on retailers, wholesalers, and growers of hemp, CBD, and THC. Consumer protections will increase, but costs for compliance are likely to rise. (newschannel5.com)

Impacts & Implications

These changes have many stakeholders worrying. Below are some of the key areas affected.

Stakeholder Potential Impact
Consumers Reduced choices; some products that contain trace amounts of THC might get pulled or reformulated. Better product standards, labeling, safety warnings. Possible price increases due to compliance costs.
Retailers / Wholesalers More regulatory overhead; licensing; stricter packaging and marketing rules; potential product recalls or loss of inventory. Some businesses may be forced to stop selling certain products.
Growers / Producers Need for more rigorous testing; possible crop losses if THC levels exceed stricter thresholds; legal risks if caught with non-compliant products.
Legal / Courts More lawsuits expected (e.g. over mislabeling, false advertising). For example, the U.S. Supreme Court permitted a truck driver to seek triple damages under RICO after a CBD product supposedly advertised as THC-free was found to contain THC. (apnews.com)
Regulators / Lawmakers Balancing act: public safety and preventing misuse (especially with minors) vs. preserving access, protecting small businesses, respecting existing legal rights of compliant operators.

Challenges & Controversies

  • Vague definitions: What counts as “quantifiable” or “any measurable” THC? Small trace amounts are hard to detect, and lab results vary. Clear thresholds matter.
  • Federal vs. state law conflicts: Even if a product is compliant with federal hemp law, state law might treat it differently or enforce additional restrictions.
  • Unintended consequences: Some proposals risk harming patients who need full‐spectrum CBD, or small hemp farms that cannot easily absorb the costs of ultra-rigid compliance.
  • Marketing & youth protection: A frequent concern in legislative debate is how products are packaged / advertised—if they mimic candy, drinks, or snacks that appeal to children.

What To Do If You’re Involved (Growers / Retailers / Consumers)

  1. Stay informed about local & state statutes: Don’t assume your product will remain legal if you cross into another state or even county.
  2. Maintain rigorous lab testing & documentation: This will help with compliance, defend against litigation, and protect brand reputation.
  3. Labeling & packaging: Use clear warning labels, avoid marketing that could be construed as targeting children, use child-resistant packaging where required.
  4. Legal counsel: As things shift, getting legal advice for both business planning and risk assessment is more important than ever.
  5. Advocacy / participate: Many of these laws are still being debated; public comments, industry associations, and customers can influence rule-making and legislative outcomes.

Outlook: What To Watch

  • Whether the “no quantifiable THC” approach becomes law at the federal level; its adoption would overhaul much of the current hemp-CBD market.
  • How many states enact laws similar to Texas or Tennessee, either banning or tightly regulating intoxicating cannabinoids.
  • Court decisions on test accuracy, consumer protection, mislabeling, and constitutional challenges (related to free speech, commerce clauses, etc.).
  • The FDA’s movement on setting binding rules for consumable CBD products, dietary supplements, cosmetics, food, etc.—if or when final rules are published.

Conclusion

The landscape for CBD, THC, and hemp is rapidly evolving. Laws once thought settled are now being re-examined. For individuals, businesses, and policy makers, the challenge is to navigate a terrain marked by increasing regulation, shifting definitions, and heightened public interest. While tighter oversight promises greater consumer safety, there’s also a risk of stifling access and innovation.

If you’re a consumer or business in this space, the key is adaptability—keep close tabs on legal updates, ensure transparency in your products, and be proactive about compliance. The next 12-24 months are likely to bring more changes that could reshape what is possible (and legal) in daily CBD / hemp / THC commerce.


Top CBD & Hemp FAQs (2025)

1) Is CBD legal—and how is “hemp” defined?

Short answer: In the U.S., hemp is federally legal if it contains no more than 0.3% delta-9 THC by dry weight. Products that test above that threshold are treated as controlled substances. State rules can add extra restrictions. USDA (2018 Farm Bill); USDA Lab Guidelines; USDA Enforcement

What it means for you: Look for brands that publish recent lab reports (COAs) showing total THC results at or below the legal limit, and check your state’s rules before purchasing or shipping.

2) Will CBD get me high?

Short answer: CBD itself is not intoxicating. However, some CBD products contain THC (including delta-8 or other isomers) that are psychoactive, which can cause impairment—especially if labeling is inaccurate. CDC Cannabis FAQ

Buyer tip: Prefer brands with third-party COAs that quantify delta-9 THC, delta-8 THC, THCa, and other cannabinoids so you know exactly what you’re taking.

3) Can CBD make me fail a drug test?

Short answer: Yes, it can. Even “hemp” products may contain more THC than the label claims, and THC exposure can trigger a positive test. CDC/NIOSH

How to lower risk: Use CBD isolate products from reputable companies, review COAs batch-by-batch, and avoid high-THC hemp derivatives (delta-8/THCa) if testing is a concern.

4) What are the common side effects and safety concerns?

Short answer: CBD is often well tolerated but can cause dry mouth, diarrhea, reduced appetite, drowsiness, and fatigue in some people. It can also interact with medications (for example, blood thinners). Mayo Clinic; WebMD

Practical advice: Start low, go slow, and talk to your clinician—especially if you take prescriptions, have liver issues, are pregnant/breastfeeding, or have underlying medical conditions.

5) Is delta-8 (and other hemp-derived THC) legal and safe?

Short answer: Delta-8 THC is psychoactive. Health effects are still being studied, labeling can be confusing, and states increasingly regulate or restrict these products. Federal and state crackdowns are evolving. CDC; Reuters (2025)

Bottom line: Treat delta-8 like THC—use cautiously, verify test results, and check your state’s rules.

6) How do I choose a high-quality CBD product?

  • COA on every batch (potency + contaminants).
  • Clear labeling (mg per serving, spectrum type).
  • Contaminant testing (pesticides, heavy metals, residual solvents, microbes).
  • Transparent sourcing & manufacturing (hemp origin, extraction method).
  • Accurate THC numbers (avoid surprises on drug tests).

These steps align with public-health guidance emphasizing accurate labeling and safety testing. CDC: About CBD

7) What’s the difference between full-spectrum, broad-spectrum, and isolate?

Full-spectrum: CBD + trace THC + minor cannabinoids/terpenes (the “entourage effect” seekers choose this; may increase drug-test risk).
Broad-spectrum: Similar to full-spectrum but THC non-detectable on COA.
Isolate: Pure CBD (typically 99%+); lowest likelihood of THC exposure.

8) How much CBD should I take—and how fast will it work?

Not medical advice. Responses vary by body weight, metabolism, product type, and goal. A common consumer pattern is 5–20 mg, assessing effects over several days, and gradually titrating.

Onset & duration by form:
Sublingual oils: onset ~15–45 min; lasts 2–6 hrs.
Edibles: onset 45–120 min; lasts 4–8 hrs.
Vapes: onset minutes; shorter duration.
Topicals: localized; timing varies.

9) Will CBD interact with my medications?

Potentially, yes. CBD can influence how your body metabolizes certain drugs (for example, anticoagulants and others). Always consult your healthcare provider before use. Mayo Clinic; WebMD

10) What are regulators warning about right now?

Themes in 2024–2025 public-health alerts: mislabeled cannabinoid content, synthetic conversions of CBD to delta-8, and consumer adverse events from mislabeled products. Expect stricter testing and clearer labels ahead. CDC HAN 2021; CDC HAN 2024

**The beliefs and opinions expressed in this blog are not those of Waterbeds 'n' Stuff.

Explore More:

Sep 18, 2025 Katy Price

Recent Posts